scholarly journals Improving the Quality of Life of Patients With Medical Devices by a Timely Analysis of Adverse Events

2019 ◽  
Vol 6 ◽  
Author(s):  
Urs P. Wyss
Keyword(s):  
Quality Of Life ◽  
Adverse Events ◽  
Medical Devices

Proton Pump Inhibitors in 2021: Pros, Cons, and Everything in Between

2021 ◽  
pp. 263451612110217
Author(s):  
Joshua A. Sloan ◽  
Philip O. Katz
Keyword(s):  
Quality Of Life ◽  
Side Effects ◽  
Adverse Events ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Drug Class ◽  
Life Threatening

The medical and lay literature has exploded with reports of adverse events associated with proton pump inhibitors over the last 10 to 15 years. The dissemination of these reports to patients and clinicians have created substantial concerns regarding what has been an exceptionally valuable drug class, dramatically improving patient quality of life, and in many cases preventing life threatening side effects of other medication. Patients are more frequently seeking to avoid these medications, and practitioners are reducing or discontinuing them to the patient’s detriment due to a misunderstanding of the data. This review will discuss the data regarding the most commonly publicized adverse events and attempt to put them in perspective.

scholarly journals Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy

2020 ◽  
Vol 4 (1) ◽  
Author(s):  
Joshua R. Niska ◽  
Cameron S. Thorpe ◽  
Michele Y. Halyard ◽  
Angelina D. Tan ◽  
Pamela J. Atherton ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Adverse Events ◽  
Head And Neck ◽  
Life Outcomes ◽  
Quality Of Life Outcomes ◽  
Patient Reported ◽  
Head And Neck Radiotherapy

The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device Implantation

ASAIO Journal ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Marc D. Samsky ◽  
Carmelo A. Milano ◽  
Salpy Pamboukian ◽  
Mark S. Slaughter ◽  
Emma Birks ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Adverse Events ◽  
Functional Capacity ◽  
Ventricular Assist Device ◽  
Assist Device ◽  
Ventricular Assist ◽  
Device Implantation ◽  
The Impact

Medical technology: A systematic review on medical devices utilized for epilepsy prediction and management

2021 ◽  
Vol 19 ◽  
Author(s):  
Jen Sze Ong ◽  
Shuet Nee Wong ◽  
Alina Arulsamy ◽  
Jessica L. Watterson ◽  
Mohd. Farooq Shaikh
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Medical Devices ◽  
Epileptic Seizures ◽  
Well Being ◽  
Sudden Unexpected Death ◽  
Unexpected Death ◽  
Long Time ◽  
Wearable Medical

: Epilepsy is a devastating neurological disorder that affects nearly 70 million people worldwide. Epilepsy causes uncontrollable, unprovoked and unpredictable seizures that reduces the quality of life of those afflicted, with 1-9 epileptic patient deaths per 1000 patient occurring annually due to sudden unexpected death in epilepsy (SUDEP). Predicting the onset of seizures and managing them may help patients from harming themselves and may improve their well-being. For a long time, electroencephalography (EEG) devices have been the mainstay for seizure detection and monitoring. This systematic review aimed to elucidate and critically evaluate the latest advancements of medical devices, besides EEG, that have been proposed for the management and prediction of epileptic seizures. A literature search was performed on three databases; PubMed, Scopus and EMBASE. Following title/abstract screening by two independent reviewers, 27 articles were selected for critical analysis in this review. These articles revealed ambulatory, non-invasive and wearable medical devices such as the in-ear EEG devices, the accelerometer-based devices and the subcutaneous implanted EEG devices might be more acceptable than traditional EEG systems. In addition, extracerebral signal-based devices may be more efficient than EEG-based systems, especially when combined with an intervention trigger. Although further studies may still be required to improve and validate these proposed systems before commercialization, these findings may give hope to epileptic patients, particularly those with refractory epilepsy, to predict and manage their seizures. The use of medical devices for epilepsy may improve patients' independence and quality of life and possibly prevent sudden unexpected death in epilepsy (SUDEP).

scholarly journals Bilateral hypoglossal nerve stimulation for treatment of adult obstructive sleep apnoea

2019 ◽  
Vol 55 (1) ◽  
pp. 1901320 ◽  
Author(s):  
Peter R. Eastwood ◽  
Maree Barnes ◽  
Stuart G. MacKay ◽  
John R. Wheatley ◽  
David R. Hillman ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Adverse Events ◽  
Nerve Stimulation ◽  
Hypoglossal Nerve ◽  
Sleep Apnoea ◽  
Serious Adverse Events ◽  
Obstructive Sleep ◽  
Device Use ◽  
Post Implantation

Background and aimHypoglossal nerve stimulation (HNS) decreases obstructive sleep apnoea (OSA) severity via genioglossus muscle activation and decreased upper airway collapsibility. This study assessed the safety and effectiveness at 6 months post-implantation of a novel device delivering bilateral HNS via a small implanted electrode activated by a unit worn externally, to treat OSA: the Genio™ system.MethodsThis prospective, open-label, non-randomised, single-arm treatment study was conducted at eight centres in three countries (Australia, France and the UK). Primary outcomes were incidence of device-related serious adverse events and change in the apnoea–hypopnoea index (AHI). The secondary outcome was the change in the 4% oxygen desaturation index (ODI). Additional outcomes included measures of sleepiness, quality of life, snoring and device use. This trial was registered with ClinicalTrials.gov, number NCT03048604.Results22 out of 27 implanted participants (63% male, aged 55.9±12.0 years, body mass index (BMI) 27.4±3.0 kg·m−2) completed the protocol. At 6 months BMI was unchanged (p=0.85); AHI decreased from 23.7±12.2 to 12.9±10.1 events·h−1, a mean change of 10.8 events·h−1 (p<0.001); and ODI decreased from 19.1±11.2 to 9.8±6.9 events·h−1, a mean change of 9.3 events·h−1 (p<0.001). Daytime sleepiness (Epworth Sleepiness Scale; p=0.01) and sleep-related quality of life (Functional Outcomes of Sleep Questionnaire-10; p=0.02) both improved significantly. The number of bed partners reporting loud, very intense snoring, or leaving the bedroom due to participant snoring decreased from 96% to 35%. 91% of participants reported device use >5 days per week, and 77% reported use for >5 h per night. No device-related serious adverse events occurred during the 6-month post-implantation period.ConclusionsBilateral HNS using the Genio™ system reduces OSA severity and improves quality of life without device-related complications. The results are comparable with previously published HNS systems despite minimal implanted components and a simple stimulation algorithm.

scholarly journals Specificity of dermatological adverse events of BCR-ABL tyrosine kinase inhibitors and their effect on quality of life of patients with chronic myeloid leukemia

2020 ◽  
pp. 72-76
Author(s):  
E. A. Shatokhina ◽  
A. G. Turkina ◽  
E. Yu. Chelysheva ◽  
O. A. Shukhov ◽  
A. N. Petrova ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Myeloid Leukemia ◽  
Adverse Events ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Myeloid Leukemia ◽  
Kinase Inhibitors ◽  
Maculopapular Rash ◽  
Abl Tyrosine Kinase

Introduction. BCR-ABL tyrosine kinase inhibitors are currently used to successfully treat chronic myeloid leukemia (CML). Drug therapy is carried out in a continuous daily mode throughout the patient’s life. Treatment with this group of drugs is associated with specific dermatological adverse events (dAE), which can lead to a change in the regimen of effective, vital therapy for CML patients.Purpose. To study the characteristics of dermatological adverse events, the severity and influence on the quality of life of BCR-ABL tyrosine kinase inhibitors.Patients and methods. The observational study included 93 patients. The clinical manifestations of dAE, their severity were evaluated, their photographs and pathomorphological studies of skin biopsy samples were performed, cases of dose reduction or drug withdrawal due to dAE were recorded. The quality of life of patients with dAE was determined based on the assessment of the dermatological index of quality of life.Results. Imatinib therapy was accompanied by a maculopapular rash in 43.3 % of patients, nilotinib caused follicular keratosis in 12.9 % of patients. In 3.2 % of patients, dasatinib caused hyperpigmentation, in 2.2 % of patients lichenoid rashes of the II degree occurred during treatment with bosutinib. Ponatinib treatment was followed by dAE in 9.7 % of patients. All dAE have an impact on the quality of life of patients, but the maculopapular rash and dyskeratotic changes are most pronounced. In a pathomorphological study, these dAE have specific features corresponding to immuno-mediated dermatitis.Conclusions. The most frequent and pronounced dAE that significantly affect the quality of life of patients with CML are a maculopapular rash and dyskeratotic skin changes: psoriasiform and lichenoid dermatitis. Clinical and pathomorphological characteristics of skin reactions make it possible in the future to determine effective methods of supportive therapy for dAE.

scholarly journals Segurança do paciente em hemodiálise

2018 ◽  
Vol 12 (12) ◽  
pp. 3360
Author(s):  
Renata De Paula Faria Rocha ◽  
Diana Lúcia Moura Pinho
Keyword(s):  
Quality Of Life ◽  
Patient Safety ◽  
Adverse Events ◽  
Renal Disease ◽  
Nursing Care ◽  
Descriptive Study ◽  
Virtual Library ◽  
Calidad De Vida ◽  
Article Analysis

RESUMOObjetivo: analisar a literatura acerca da segurança do paciente em hemodiálise. Método: trata-se de um estudo bibliográfico, descritivo, tipo revisão integrativa, por meio de pesquisa em artigos publicados entre os anos de 2006 a 2016, em português, inglês ou espanhol; coletados nas bases de dados Medline, Lilacs, BDENF e Biblioteca Virtual SciELO e os resultados apresentado em figura. Resultados: compôs-se a amostra deste estudo por seis artigos. Agruparam-se as informações após a análise dos artigos, em três categorias: segurança do paciente em hemodiálise; fatores que afetam a segurança do paciente em hemodiálise e estratégias para a segurança do paciente em hemodiálise. Conclusão: torna-se importante que a equipe da hemodiálise aprofunde os seus conhecimentos acerca da segurança do paciente para atuar, de forma proativa, na prevenção de eventos adversos garantindo, assim, a segurança do paciente e uma melhor qualidade de vida ao paciente com doença renal crônica em tratamento hemodialítico. Descritores: Segurança do Paciente; Enfermagem; Diálise Renal; Cuidados de Enfermagem; Enfermagem em Nefrologia; Avaliação em Enfermagem.ABSTRACT Objective: to analyze the literature on the safety of patients on hemodialysis. Method: this is a bibliographical, descriptive study, of integrative review type, through research in articles published between the years 2006 to 2016, in Portuguese, English or Spanish; collected in the databases Medline, Lilacs, BDENF and SciELO Virtual Library and the results presented in figure. Results: the sample of this study was composed by six articles. The information after article analysis was grouped into three categories: patient safety on hemodialysis; factors that affect patient safety on hemodialysis and strategies for patient safety on hemodialysis. Conclusion: it is important that the hemodialysis team deepens their knowledge about patient safety to proactively act in the prevention of adverse events, thus ensuring patient safety and a better quality of life for patients with illness renal disease on hemodialysis. Descriptors: Patient Safety; Nursing; Renal Dyalisis; Nursing Care; Nephrology Nursing; Nursing Assessment.RESUMEN Objetivo: analizar la literatura acerca de la seguridad del paciente en hemodiálisis. Método: se trata de un estudio bibliográfico y descriptivo, revisión de tipo integrador, a través de los artículos de investigación publicados entre 2006 a 2016, en portugués, Inglés o Español; recogidos en las bases de datos Medline, Lilacs, BDENF y Biblioteca Virtual SciELO y los resultados presentados en figura. Resultados: se compuso la muestra de este estudio por seis artículos. Se agruparon las informaciones después del análisis de los artículos, en tres categorías: seguridad del paciente en hemodiálisis; factores que afectan la seguridad del paciente en hemodiálisis y estrategias para la seguridad del paciente en hemodiálisis. Conclusión: es importante que el equipo de la hemodiálisis profundice sus conocimientos acerca de la seguridad del paciente para actuar de forma proactiva en la prevención de eventos adversos garantizando así la seguridad del paciente y una mejor calidad de vida al paciente con enfermedad renal crónica en tratamiento hemodialítico. Descriptores: Seguridad del Paciente; Enfermería; Diálisis Renal; Atención de Enfermería; Enfermería en Nefrología; Evaluación en Enfermería.

Sign in / Sign up

Export Citation Format

Share Document